Factors affecting the quality of therapeutic proteins in recombinant Chinese hamster ovary cell culture

TK Ha, D Kim, CL Kim, LM Grav, GM Lee - Biotechnology Advances, 2022 - Elsevier
Chinese hamster ovary (CHO) cells are the most widely used mammalian host cells for the
commercial production of therapeutic proteins. Fed-batch culture is widely used to produce …

Biopharmaceutical quality control with mass spectrometry

S Liu, BL Schulz - Bioanalysis, 2021 - Taylor & Francis
Mass spectrometry (MS) is a powerful technique for protein identification, quantification and
characterization that is widely applied in biochemical studies, and which can provide data …

The role of N-glycosylation in spike antigenicity for the SARS-CoV-2 gamma variant

CL Pegg, N Modhiran, RH Parry, B Liang… - …, 2024 - academic.oup.com
The emergence of SARS-CoV-2 variants alters the efficacy of existing immunity towards the
viral spike protein, whether acquired from infection or vaccination. Mutations that impact N …

Biomechanical and Functional Features of the Carrier Erythrocytes Prolonging Circulation Time of Biotherapeutic Targeted to Glycophorin A

AD Peshkova, TV Brysgel, P Mody, J Nong… - Bioconjugate …, 2025 - ACS Publications
Red blood cells (RBCs) serve as natural transporters and can be modified to enhance the
pharmacokinetics and pharmacodynamics of a protein cargo. Affinity targeting of Factor IX …

Multiplex, multimodal mapping of variant effects in secreted proteins

NA Popp, RL Powell, MK Wheelock, BD Zapp… - bioRxiv, 2024 - biorxiv.org
Despite widespread advances in DNA sequencing, the functional consequences of most
genetic variants remain poorly understood. Multiplexed Assays of Variant Effect (MAVEs) …

Hemophilia A: Diagnosis and Management

Z Kaya, N Safarian, B Pezeshkpoor… - … Disorders: Diagnosis and …, 2023 - Springer
Hemophilia A is an inherited X-linked recessive bleeding disorder that accounts for about
80% of cases of hemophilia, occurs in~ 5 and~ 20 per 100,000 male births, and is caused by …

Hemophilia B: Diagnosis and Management

G Castaman, H Motlagh, B Pezeshkpoor - Congenital Bleeding Disorders …, 2023 - Springer
Hemophilia B or Christmas disease is an X-chromosome-linked recessive bleeding disorder
caused by the deficiency of coagulation factor IX (FIX), with a prevalence of~ 1 per 30,000 …

Recent advances in the production of recombinant factor IX: bioprocessing and cell engineering

AC Beauglehole, D Roche Recinos… - Critical Reviews in …, 2023 - Taylor & Francis
Appropriate treatment of Hemophilia B is vital for patients' quality of life. Historically, the
treatment used was the administration of coagulation Factor IX derived from human plasma …

Mutational analysis of a South African haemophilia B population

C Bester - 2023 - scholar.ufs.ac.za
Abstract Introduction and Aim: Haemophilia B is an X-linked recessive bleeding disorder
characterised by a deficiency of coagulation factor IX (FIX), due to a wide spectrum of …

[图书][B] Building multiplexed genomic tools for editing and interpreting human variation

NA Popp - 2023 - search.proquest.com
Advances in DNA sequencing over the past twenty years have led to an unprecedented
expansion in our ability to read DNA sequences and find genetic variation in individuals …